BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 24562704)

  • 1. [Colorectal cancer screening: evidence and implementation].
    Brenner H; Hoffmeister M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Mar; 57(3):302-6. PubMed ID: 24562704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for colorectal cancer screening.
    Bretthauer M
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):417-25. PubMed ID: 20833346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
    Sharaf RN; Ladabaum U
    Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colon Cancer Screening - Is It Time Yet?
    Bhurgri H; Samiullah S
    J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer screening: the time to act is now.
    Brenner H; Stock C; Hoffmeister M
    BMC Med; 2015 Oct; 13():262. PubMed ID: 26459270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer screening.
    Bretthauer M
    J Intern Med; 2011 Aug; 270(2):87-98. PubMed ID: 21575082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for Colorectal Cancer and Evolving Issues for Physicians and Patients: A Review.
    Lieberman D; Ladabaum U; Cruz-Correa M; Ginsburg C; Inadomi JM; Kim LS; Giardiello FM; Wender RC
    JAMA; 2016 Nov; 316(20):2135-2145. PubMed ID: 27893135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based programs for increasing colorectal cancer screening in the United States.
    Verma M; Sarfaty M; Brooks D; Wender RC
    CA Cancer J Clin; 2015; 65(6):497-510. PubMed ID: 26331705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention and early detection of colorectal cancer in average risk population--summary of a meeting and the Israeli gastroenterology policy].
    Strul H; Elyakim R; Halpern Z; Arber N
    Harefuah; 2003 Mar; 142(3):223-6, 236. PubMed ID: 12696479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for colon cancer: A test for occult blood.
    Khakimov N; Khasanova G; Ershova K; Gibadullina L; Vetkina T; Lobisheva G; Chumakova A
    Int J Risk Saf Med; 2015; 27 Suppl 1():S110-1. PubMed ID: 26639687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and primary prevention of colorectal cancer: a review of sex-specific and site-specific differences.
    Massat NJ; Moss SM; Halloran SP; Duffy SW
    J Med Screen; 2013; 20(3):125-48. PubMed ID: 24197771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer screening by colonoscopy: putting it into perspective.
    Vleugels JL; van Lanschot MC; Dekker E
    Dig Endosc; 2016 Apr; 28(3):250-9. PubMed ID: 26257272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
    Quintero E
    Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies in screening for colon carcinoma.
    de Wijkerslooth TR; Bossuyt PM; Dekker E
    Neth J Med; 2011 Mar; 69(3):112-9. PubMed ID: 21444935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Implementing an Organised Colorectal Cancer Screening Programme in Germany: Opportunities and Challenges].
    Haug U; Rösch T; Hoffmeister M; Katalinic A; Brenner H; Becker N
    Gesundheitswesen; 2015 Nov; 77(11):869-74. PubMed ID: 25025294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
    Tinmouth J; Lansdorp-Vogelaar I; Allison JE
    Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer mortality prevented by use and attributable to nonuse of colonoscopy.
    Stock C; Knudsen AB; Lansdorp-Vogelaar I; Haug U; Brenner H
    Gastrointest Endosc; 2011 Mar; 73(3):435-443.e5. PubMed ID: 21353840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of screening for colorectal cancer.
    Garborg K; Holme Ø; Løberg M; Kalager M; Adami HO; Bretthauer M
    Ann Oncol; 2013 Aug; 24(8):1963-72. PubMed ID: 23619033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening: a global overview of existing programmes.
    Schreuders EH; Ruco A; Rabeneck L; Schoen RE; Sung JJ; Young GP; Kuipers EJ
    Gut; 2015 Oct; 64(10):1637-49. PubMed ID: 26041752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.